RecruitingNot ApplicableNCT06739759
Ovarian Hyperstimulation Syndrome Prevention
Prophylaxis Against Ovarian Hyperstimulation Syndrome in PCOS Women
Sponsor
Aljazeera Hospital
Enrollment
300 participants
Start Date
Nov 17, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Ovarian hyperstimulation is a very hazardous complication of ICSI
Eligibility
Sex: FEMALEMin Age: 19 YearsMax Age: 42 Years
Inclusion Criteria1
- Women with PCOS coming for ICSI
Exclusion Criteria1
- Women who donnot have PCOS
Interventions
DRUGAntagonist protocol for IVF
antagonist protocol with triggering by Decapeptyl
DRUGModified Agonist protocol for IVF with additive treatments as HCQ
giving additive drugs to agonist protocolas HCQ
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06739759